CAMEKTRUS Trademark

Trademark Overview


On Tuesday, August 16, 2011, a trademark application was filed for CAMEKTRUS with the United States Patent and Trademark Office. The USPTO has given the CAMEKTRUS trademark a serial number of 85399272. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 15, 2013. This trademark is owned by GlaxoSmithKline LLC. The CAMEKTRUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
camektrus

General Information


Serial Number85399272
Word MarkCAMEKTRUS
Filing DateTuesday, August 16, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 15, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 19, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Party NameGlaxoSmithKline LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Trademark Events


Event DateEvent Description
Monday, April 15, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 15, 2013ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 15, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 13, 2012EXTENSION 1 GRANTED
Thursday, September 13, 2012EXTENSION 1 FILED
Thursday, September 13, 2012TEAS EXTENSION RECEIVED
Tuesday, March 13, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2012PUBLISHED FOR OPPOSITION
Thursday, January 5, 2012APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 5, 2012TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 28, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 7, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2011ASSIGNED TO EXAMINER
Friday, August 19, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 19, 2011NEW APPLICATION ENTERED IN TRAM